|
Re: Blood test coming for Earlier Detection of Alzheimer's
|
2
|
Resverlogix Corp.
|
Mar 06, 2018 10:58AM
|
|
Re: Collaborating with the Supreme Council of the Arab-African Economy
|
2
|
Resverlogix Corp.
|
Nov 04, 2021 06:01PM
|
|
Brand Building
|
2
|
Resverlogix Corp.
|
Nov 08, 2017 06:04PM
|
|
CEO Compensation
|
2
|
Zenith Epigenetics
|
Oct 18, 2022 02:07PM
|
|
Re: Blistering volume today
|
2
|
Resverlogix Corp.
|
Aug 31, 2018 03:45PM
|
|
Re: Worst Communicating Company in History?
|
2
|
Zenith Epigenetics
|
Jun 13, 2017 01:29PM
|
|
Re: Fun with Numbers
|
2
|
Resverlogix Corp.
|
Oct 18, 2022 02:52PM
|
|
Re: CRISPR vs. BET inhibitors
|
2
|
Resverlogix Corp.
|
Jan 11, 2016 03:48PM
|
|
Re: A Shenzhen Hepalink M&A type deal...
|
2
|
Resverlogix Corp.
|
Jan 05, 2018 06:27PM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 01, 2018 05:17PM
|
|
Re: Zenith poster from AACR EORTC meeting and Annual General/Special meeting date
|
2
|
Resverlogix Corp.
|
Nov 16, 2015 11:54AM
|
|
Re: Interesting.
|
2
|
Resverlogix Corp.
|
Nov 23, 2021 11:39AM
|
|
Re: Another Report of Exempt Distribution
|
2
|
Resverlogix Corp.
|
Mar 19, 2023 08:35PM
|
|
Re: TSX Review
|
2
|
Resverlogix Corp.
|
Mar 13, 2018 09:02PM
|
|
Hepalink buys Cytovance Biologics
|
2
|
Resverlogix Corp.
|
Aug 24, 2015 05:00PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 22, 2020 05:45PM
|
|
Re: Q2 Zenith/Resverlogix Events
|
2
|
Zenith Epigenetics
|
Apr 12, 2016 05:10PM
|
|
Re: OTC Trading questions
|
2
|
Zenith Epigenetics
|
Mar 03, 2022 12:04PM
|
|
What if RRR MACE is significant at 90% confidence?
|
2
|
Resverlogix Corp.
|
Apr 23, 2018 03:16PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 22, 2020 06:10PM
|
